Lipidomic profiling of the cerebrospinal fluid in moyamoya angiopathy patients
Our findings highlighted a strong pro-inflammatory environment in MA CSF. These preliminary hallmarks could be helpful to decipher the complex MA pathogenesis, by supplying candidate biomarkers for patient stratification.
Authors
- Gemma Gorla (ORCID: https://orcid.org/0000-0001-8483-3509)
- Isabella Canavero (ORCID: https://orcid.org/0000-0002-0141-0437)
- Francesco Acerbi (ORCID: https://orcid.org/0000-0002-4063-3924)
- Giuliana Pollaci (ORCID: https://orcid.org/0000-0002-0256-9706)
- Laura Gatti (ORCID: https://orcid.org/0000-0001-6751-5031)
- Michele Dei (ORCID: https://orcid.org/0000-0001-7359-8558)
- Tatiana Carrozzini (ORCID: https://orcid.org/0000-0001-5752-1374)
- Paolo Ferroli (ORCID: https://orcid.org/0000-0002-8744-8857)
- Ignazio G. Vetrano (ORCID: https://orcid.org/0000-0003-0664-9700)
- Antonella Potenza (ORCID: https://orcid.org/0000-0001-6811-6112)
- Anna Bersano (ORCID: https://orcid.org/0000-0002-2493-628X)
- Nicola Rifino (ORCID: https://orcid.org/0000-0002-0423-8759)
- Rita Clara Paroni (ORCID: https://orcid.org/0000-0002-3186-8860)
Institutions
- University of Pisa (IT)
- University of Milan (IT)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- Azienda Ospedaliera Universitaria Pisana (IT)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1186/s13023-025-03782-5
- Primary Topic
- Moyamoya disease diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Ministero della Salute